FDA OKs PerkinElmer Duchenne test

The FDA approves PerkinElmer’s (PKI +1.2%) GSP Neonatal Creatinine Kinase-MM kit as an aid to newborn screening for Duchenne muscular dystrophy (DMD).

Based on a heel stick sample, the test measures the concentration of a type of protein called CK-MM which is elevated when muscles are damaged.

https://seekingalpha.com/news/3525917-fda-oks-perkinelmer-dmd-test